Epithalon
Recherche publiée et base de preuves
Epithalon (also written Epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), derived from the pineal gland extract preparation Epithalamin. Published work reports induction of telomerase activity and telomere elongation in cultured human cells, modulation of circadian and pineal gene expression, antioxidant effects, and extension of median lifespan in Drosophila and rodent models. The great majority of this literature originates from a single Russian research group, with a small number of independent in vitro replications appearing between 2022 and 2025. No registered, placebo-controlled randomised trial of the tetrapeptide in humans has been published in the indexed literature.
- L'Epithalon est un tétrapeptide synthétique dérivé d'un extrait de glande pinéale.
- Des études ont rapporté une induction de la télomérase dans des cellules humaines et une extension de la durée de vie chez les mouches et les rongeurs.
- Presque toutes les preuves proviennent d'un groupe de recherche russe avec peu de réplication indépendante.
21 études · 8 depuis 2023 · plus récente 2026
- Études citées
- 21
- Publiées 2023+
- 8
- Article le plus récent
- 2026
- Dernière révision
- oct. 2026
Thèmes récurrents dans la littérature
- telomerase induction
- telomere length
- pineal gland and melatonin regulation
- circadian clock gene expression
- geroprotection and lifespan
- oxidative stress and antioxidant activity
- epigenetic chromatin modification
- cellular senescence markers
Identifiants du composé
- CAS
- 307297-39-8
- PubChem
- 219042
Recommandé par un comité consultatif de la FDA.
Le 23–24 July 2026, le comité consultatif sur la préparation pharmaceutique de la FDA a examiné Epithalon, entendu sous le nom Epitalon, pour la liste 503A Bulks et a recommandé son ajout. Heard under the spelling Epitalon and recommended on a divided vote. Published accounts of the meeting differ on the exact tally, so none is quoted here.
Ce n'est pas une approbation. Le comité conseille ; il ne décide pas. La recommandation n'est pas contraignante, la FDA n'a pas terminé la réglementation qui changerait formellement quoi que ce soit, et l'inclusion dans la liste 503A Bulks n'équivaut pas à l'approbation FDA d'un médicament. La liste régit également la préparation pharmaceutique pour les patients, qui est une activité distincte de la fourniture à usage de recherche uniquement.
Ce que le vote consultatif de juillet 2026 a réellement accompli décrit le processus, les autres composés examinés et les quatre choses que le vote est régulièrement mal interprété comme signifiant.
Ce qu'est Epithalon, chimiquement.
- Formule moléculaire
- C14H22N4O9
- Masse moléculaire
- 390.35 g/mol
- Numéro CAS
- 307297-39-8
- PubChem CID
- 219042
Epitalon, Epithalone
Ces chiffres proviennent de la fiche PubChem pour ce composé et décrivent la base libre. Le peptide lyophilisé est normalement fourni sous forme de sel d'acétate ou de trifluoroacétate et contient de l'eau résiduelle, donc la masse de poudre dans un flacon ne correspond pas à la quantité suggérée par la masse moléculaire ci-dessus. La pureté chromatographique sur un certificat d'analyse ne résout pas cette différence non plus — comment lire un certificat d'analyse explique pourquoi.
21 études publiées.
Classées par rigueur du protocole d'étude, puis par date. Chaque entrée renvoie à sa source pour que les résultats puissent être vérifiés dans l'article plutôt que pris sur parole.
- 01Clinique humaine2024· Russian (English abstract)
Peptidergic regulation of expression of cellular aging marker proteins in buccal epithelium
Ivko OM, et al. · Advances in Gerontology (Uspekhi Gerontologii) · buccal epithelial cells sampled from human subjects with disturbed melatonin secretion
AEDG peptide administration was associated with reduced expression of the senescence-associated proteins p16, p21 and p53 in buccal epithelium. Circadian gene expression and melatonin secretion indices shifted toward values seen in younger subjects.
- 02Clinique humaine2020· Russian (English abstract)
[AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated aging.].
Ivko OM, et al. · Adv Gerontol · clinical study in middle-aged people with reduced melatonin-producing pineal function (accelerated pineal ageing); n, route, duration and any control group not stated in the abstract
The AEDG peptide was reported to increase urinary excretion of the melatonin metabolite 6-sulfatoxymelatonin in middle-aged people. In people with reduced melatonin production it normalised raised expression of the circadian genes Clock and Csnk1e in leukocytes and doubled the reduced expression of Cry2 in blood lymphocytes.
- 03Clinique humaine2011
Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up.
Korkushko OV, et al. · Bull Exp Biol Med · randomized comparative study, n=79 elderly coronary patients (39 epithalamin + basic therapy vs 40 basic therapy alone), 3 years of treatment courses, 15-year follow-up
Patients receiving six courses of epithalamin over 3 years in addition to basic therapy showed slower age-related decline of cardiovascular function and physical endurance, normalised circadian melatonin production and carbohydrate/lipid metabolism, and significantly lower mortality than controls.
- 04Clinique humaine2007· Russian (English abstract)
[Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people].
Korkushko OV, et al. · Adv Gerontol · clinical and primate study: elderly people and old monkeys given pineal peptide preparations, both the extract Epithalamin and the synthetic tetrapeptide Epitalon; n not stated in the abstract
Both preparations were reported to restore night-time release of endogenous melatonin and normalise its circadian rhythm in plasma; in elderly people with pineal insufficiency night melatonin rose. The abstract does not report results separately for Epitalon and Epithalamin, and the authors stated the preparations had no side effects.
- 05Clinique humaine2004
Effect of peptide preparation epithalamin on circadian rhythm of epiphyseal melatonin-producing function in elderly people.
Korkushko OV, et al. · Bull Exp Biol Med · randomized clinical study in healthy elderly people (n not stated in abstract)
A course of epithalamin (pineal peptide preparation) modulated the circadian rhythm of plasma melatonin: night-time melatonin rose in subjects with initially low pineal activity and tended to fall in subjects with normal pineal function.
- 06Clinique humaine2003
Peptides of pineal gland and thymus prolong human life
Khavinson VKh, Morozov VG · Neuro Endocrinology Letters · 266 elderly subjects followed 6-8 years, thymic (Thymalin) and pineal (Epithalamin) peptide preparations
The authors reported reduced mortality in peptide-treated elderly cohorts relative to controls over 6 to 8 years of follow-up, with the largest reduction in the combined Thymalin plus Epithalamin group. The report describes an open, non-randomised observational design and used the pineal extract preparation Epithalamin rather than the synthetic AEDG tetrapeptide.
- 07Clinique humaine2002
Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa.
Khavinson V, et al. · Neuro Endocrinol Lett · controlled clinical trial in patients with degenerative retinal lesions (n not stated in abstract) plus Campbell rat model of retinitis pigmentosa
In Campbell rats, Epitalon preserved retinal morphology and increased bioelectric and functional retinal activity. In patients with degenerative retinal lesions, a positive clinical effect was reported in 90% of cases.
- 08Animal in vivo2003
Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice
Anisimov VN, et al. · Biogerontology · female Swiss-derived SHR mice, lifelong monthly subcutaneous dosing, lifespan and tumour incidence study
Epitalon-treated female SHR mice showed an increase in maximum lifespan of approximately 12 percent relative to controls. Incidence of leukaemia was reduced, and the authors reported no increase in total spontaneous tumour incidence.
- 09Animal in vivo2002
Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN, et al. · Int J Cancer · female HER-2/neu transgenic mice, Epitalon vs saline vs Vilon, monthly injection cycles from age 2 months
Epitalon reduced the cumulative number and maximum size of spontaneous mammary tumors and the size (not number) of lung metastases, with 3.7-fold lower HER-2/neu mRNA expression in tumors versus controls. The comparator peptide Vilon increased mammary cancer incidence.
- 10Animal in vivo2001
Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys
Khavinson V, Goncharova N, Lapin B · Neuro Endocrinology Letters · old rhesus monkeys (Macaca mulatta), melatonin and cortisol circadian profiling
Epitalon administration increased evening melatonin output in aged monkeys whose nocturnal melatonin rise had flattened. Disturbed circadian cortisol profiles were reported to move toward the pattern seen in young animals.
- 11Animal in vivo2000
Effect of epitalon on the lifespan increase in Drosophila melanogaster
Khavinson VK, et al. · Mechanisms of Ageing and Development · Drosophila melanogaster, peptide administered during larval development
Epitalon added to the medium during development increased adult Drosophila lifespan by roughly 11 to 16 percent. The effect was reported to be independent of concentration across the very low doses tested.
- 12In vitro2025
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity
Al-Dulaimi S, Thomas R, Matta S, Roberts T · Biogerontology · human normal and breast cancer cell lines; qPCR telomere length assay and immunofluorescence
Epitalon exposure was associated with increased telomere length in the cell lines tested, attributed to telomerase upregulation in normal cells and to alternative lengthening of telomeres (ALT) activity in cancer lines. A correction to this article was published in Biogerontology in November 2025 (PMID 41240216, doi 10.1007/s10522-025-10326-8).
- 13In vitro2025
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy
Gatta M, et al. · Stem Cell Reviews and Reports · human retinal pigment epithelial cells under high-glucose conditions (in vitro diabetic retinopathy model)
High-glucose culture delayed scratch-wound closure and raised reactive oxygen species in retinal pigment epithelial cells. Epitalon treatment restored wound closure and reduced markers of hyperglycaemia-induced epithelial-mesenchymal transition and fibrosis.
- 14In vitro2025
Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development
Ullah S, et al. · Life Sciences · bovine oocytes and cumulus cells; in vitro maturation and post-thaw embryo culture
Epitalon supplementation increased telomerase activity in bovine oocytes and cumulus cells and raised in vitro maturation rates. Post-thaw blastocyst development and mitochondrial function measures were also improved relative to untreated controls.
- 15In vitro2024
Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes
Kraskovskaya N, et al. · International Journal of Molecular Sciences · induced neurons transdifferentiated from human fibroblasts of aged donors
AEDG and related short peptides increased dendritic outgrowth in induced neurons derived from aged donor fibroblasts. Markers of oxidative DNA damage were reduced in treated cultures.
- 16In vitro2023
Epigenetic Modification Under the Influence of Peptide Bioregulators on the "Old" Chromatin
Lezhava T, Jokhadze T, Monaselidze J, et al. · Georgian Medical News · cultured lymphocytes from elderly human donors
Peptide bioregulators including the AEDG tetrapeptide induced decondensation of constitutive heterochromatin in lymphocytes from elderly donors. Each peptide acted selectively on particular chromosome regions rather than uniformly across the genome.
- 17In vitro2022
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro
Yue X, et al. · Aging (Albany NY) · mouse oocytes cultured 24 h post-ovulation
Epitalon reduced reactive oxygen species accumulation and preserved mitochondrial membrane potential in post-ovulatory aged mouse oocytes. Spindle and chromosome abnormalities associated with post-ovulatory ageing were attenuated in treated oocytes.
- 18In vitro2020
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism
Khavinson V, et al. · Molecules · human gingival mesenchymal stem cells undergoing neuronal differentiation, plus molecular docking
AEDG peptide increased expression of neurogenesis markers including Nestin, GAP43, beta-tubulin III and doublecortin during neuronal differentiation. Molecular modelling indicated binding of the peptide to histone proteins and to DNA, which the authors proposed as an epigenetic mechanism.
- 19In vitro2003
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Khavinson VKh, et al. · Bulletin of Experimental Biology and Medicine · human fetal fibroblast culture at the Hayflick limit
Addition of Epithalon to human somatic cell cultures induced telomerase activity and telomere elongation. The authors reported that treated cultures underwent additional population doublings beyond the expected replicative limit. This is the foundational report underlying subsequent telomerase claims for the peptide.
- 20Revue2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Mavrych V, et al. · Frontiers in Aging · narrative review of nine therapeutic peptides used or investigated in aging research, including Epithalon
The review placed Epithalon among investigational geroprotective peptides whose mechanistic rationale rests largely on preclinical data. The authors concluded that investigational peptides in this class require validation through well-designed clinical trials before therapeutic claims can be supported.
- 21Revue2025
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties
Araj SK, et al. · International Journal of Molecular Sciences · narrative review covering approximately 25 years of Epitalon literature
The review summarised reported geroprotective, neuroendocrine, antioxidant and neuroprotective effects of the AEDG tetrapeptide. The authors stated that substantial gaps remain in the understanding of its molecular mechanism and clinical relevance.
Ce que ces preuves n'établissent pas.
The Epithalon evidence base is dominated by a single research group, the St Petersburg Institute of Bioregulation and Gerontology (Khavinson and colleagues), is largely published in Russian-language journals such as Uspekhi Gerontologii and Byulleten Eksperimentalnoi Biologii i Meditsiny, and has seen very little independent replication; the small number of independent papers are in vitro only. There are no published randomised, placebo-controlled, registered clinical trials of the synthetic AEDG tetrapeptide, most human reports used the pineal extract preparation Epithalamin in small open-label studies, some described as randomised but none placebo-controlled or blinded, the few in which the synthetic tetrapeptide itself was given are small Russian studies (one gave it together with Epithalamin), and human pharmacokinetics, dose-response and long-term safety, including any oncological risk from telomerase induction, remain uncharacterised.
Questions courantes sur la recherche.
- What is Epithalon?
Epithalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, abbreviated AEDG. It is the defined single-sequence analogue of Epithalamin, a pineal-gland polypeptide extract studied in Russian gerontology research, and it is supplied here as a lyophilised research material.
- What does the telomerase research actually show?
One frequently cited in-vitro study reported that adding the peptide to telomerase-negative human fetal fibroblast cultures induced expression of the telomerase catalytic subunit, measurable enzymatic activity, and telomere elongation. That is a cell-culture observation. It has not been shown to translate into any clinical outcome, and nothing here should be read as a claim about ageing in humans.
- How does Epithalon differ from Pinealon?
Both are short bioregulator peptides from the same Russian research programme, but they are different sequences with different literature. Epithalon is the tetrapeptide Ala-Glu-Asp-Gly studied mainly in pineal and telomere contexts; Pinealon is the tripeptide Glu-Asp-Arg studied mainly in neuronal models.
Disponible dans notre catalogue
À des fins de recherche uniquement. Non destiné à la consommation humaine, au diagnostic, au traitement ou à la prévention de toute condition. Rien sur cette page ne constitue un avis médical, et aucune étude résumée ici ne doit être considérée comme une recommandation.